EUVIMEDEUVIMED entdecken
Crossref

Deferiprone modulates osteoclast‐mediated bone resorption while preserving axial bone microstructure in β‐thalassemic mice with iron overload

Ratchaneevan Aeimlapa, Jarinthorn Teerapornpuntakit, Saovaros Svasti, Jiraporn Panmanee, Pathnaree Wattano, Jirawan Thongbunchoo, Benjaporn Kiatpakdee, Parinda Jamrus, Nuttanan Pholngam, Narattaphol Charoenphandhu iD

FEBS Letters · 18.11.2026

DOI: 10.1002/1873-3468.70504 ↗

Kurz gefasst

Fachartikel in der Zeitschrift FEBS Letters, online erschienen am 18.11.2026. Verfasst von Ratchaneevan Aeimlapa und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center of Calcium and Bone Research (COCAB), Faculty of Science, Mahidol University, Bangkok, Thailand. Die Arbeit nennt 68 Literaturangaben. Gefördert von: The high-resolution multiphoton imaging platform and the ultra-high resolution μCT platform were supported by Mahidol University-Frontier Research Facility (MU…, The 3D Holotomography Platform for Drug Discovery was supported by Science and Technology Development Fund (ST), Thailand Science Research and Innovation (TSRI…, National Research Council of Thailand (NRCT) to R. Aeimlapa.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Deferiprone (DFP), an iron chelator, is widely used to alleviate iron overload. However, its effects on bone metabolism remain incompletely understood. Herein, we demonstrated that DFP reduced osteoblast viability and in vitro mineralization. Interestingly, DFP delayed osteoclastogenesis, suppressed osteoclast marker expression, and appeared to influence iron efflux by upregulating Nrf2 and ferroportin‐1. Although DFP effectively reduced iron accumulation in bone, it did not reverse persistent microstructural defects in the axial skeleton of β‐thalassemic mice. Under high‐iron conditions, DFP appeared to increase osteoclast turnover, leading to a transient accumulation of multinucleated osteoclasts followed by enhanced apoptosis. Collectively, our findings suggest a trade‐off whereby reduced iron toxicity is accompanied by attenuated bone formation and resorption in β‐thalassemic mice.

Schlagwörter

Stichwörter der Autor:innen

DMT1 blocker‐2bone microstructuredeferiprone (DFP)iron chelatorosteoclastthree‐dimensional (3D) holotomographyβ‐thalassemia

Autor:innen und Institutionen

  • Center of Calcium and Bone Research (COCAB), Faculty of Science, Mahidol University, Bangkok, Thailand.
  • Department of Physiology, Faculty of Science, Mahidol University, Bangkok, Thailand.
  • Physiology Division, Preclinical Science, Faculty of Medicine, Thammasat University, Pathum Thani, Thailand.
  • Thalassemia Research Center, Institute of Molecular Biosciences, Mahidol University, Nakhon Pathom, Thailand.
  • Research Center for Neuroscience, Institute of Molecular Biosciences, Mahidol University, Nakhon Pathom, Thailand.
  • Graduate Program in Molecular Medicine, Faculty of Science, Mahidol University, Bangkok, Thailand.

ORCID-Profile: Narattaphol Charoenphandhu

Förderung

  • The high-resolution multiphoton imaging platform and the ultra-high resolution μCT platform were supported by Mahidol University-Frontier Research Facility (MU…
  • The 3D Holotomography Platform for Drug Discovery was supported by Science and Technology Development Fund (ST), Thailand Science Research and Innovation (TSRI…
  • National Research Council of Thailand (NRCT) to R. Aeimlapa
  • Research Cluster Development Fund, Mahidol University (to N. Charoenphandhu)
  • P. Wattano was supported by Burapha University-TSRI-NSRF (Fundamental Fund; fiscal year 2025-2026)
  • NSRF via the Program Management Unit for Human Resources & Institutional Development, Research and Innovation (PMU-B) to N. Charoenphandhu
  • Fundamental Fund through Mahidol University [fiscal year 2025-2026 by National Science Research and Innovation Fund (NSRF); to N. Charoenphandhu]
  • The Central Instrumental Facility (CIF/CNI), Faculty of Science, Mahidol University (to R. Aeimlapa and N. Charoenphandhu)

Zitieren

APA

Aeimlapa, R., Teerapornpuntakit, J., Svasti, S., Panmanee, J., Wattano, P., Thongbunchoo, J., Kiatpakdee, B., Jamrus, P., Pholngam, N., & Charoenphandhu, N. (2026). Deferiprone modulates osteoclast‐mediated bone resorption while preserving axial bone microstructure in β‐thalassemic mice with iron overload. FEBS Letters. https://doi.org/10.1002/1873-3468.70504

Vancouver

Aeimlapa R, Teerapornpuntakit J, Svasti S, Panmanee J, Wattano P, Thongbunchoo J, et al. Deferiprone modulates osteoclast‐mediated bone resorption while preserving axial bone microstructure in β‐thalassemic mice with iron overload. FEBS Letters. 2026. doi:10.1002/1873-3468.70504

BibTeX
@article{Aeimlapa2026,
  author = {Aeimlapa, Ratchaneevan and Teerapornpuntakit, Jarinthorn and Svasti, Saovaros and Panmanee, Jiraporn and Wattano, Pathnaree and Thongbunchoo, Jirawan and Kiatpakdee, Benjaporn and Jamrus, Parinda and Pholngam, Nuttanan and Charoenphandhu, Narattaphol},
  title = {Deferiprone modulates osteoclast‐mediated bone resorption while preserving axial bone microstructure in β‐thalassemic mice with iron overload},
  journal = {FEBS Letters},
  year = {2026},
  doi = {10.1002/1873-3468.70504}
}
Kostenlos starten →